In July 2021, Stop TB Partnership’s Executive Committee approved US$6.14 million for Wave 9 funding to be awarded to 11 projects, in 8 countries, to focus their efforts on innovative approaches to address drug resistant tuberculosis (DR-TB).With funding support from USAID and Global Affairs Canada, TB REACH Wave 9 grantees will help reduce initial or pre-treatment loss to follow up for people with DR-TB, by expanding access to new, all-oral treatment regimens, and improving treatment adherence and outcomes for people with DR-TB.

In Wave 9, only local, non-governmental organizations were eligible for funding, and together with the support of USAID, TB REACH will work with the organizations on a capacity assessment as part of a development plan to help grantees to improve and continue their funding efforts.

The Wave 9 Call for Proposals was launched in January 2021 and received almost 300 applications from 24 countries with a total funding request of USD 145 million. All completed proposals were reviewed intensively by an independent Proposal Review Committee (PRC), who selected 48 applicants to be invited to submit a more in-depth stage 2 proposal. These applications underwent another round of diligent and careful review by the PRC. After an 8-day review meeting, the PRC recommended 11 projects from 8 countries for funding.

TB REACH Wave 9 Grantees

Organization Country Project Category Requested Budget (USD)
Interactive Research & Development Ltd. Bangladesh Implementation of new DR-TB treatment regimens $600,000
REACH Ethiopia Ethiopia Improving treatment adherence and outcomes $590,037
Baptist Church Trust Association (BCTA) India Improving treatment adherence and outcomes $580,294
Innovators In Health (India) India Linkage to care to reduce pre-treatment loss to follow-up $593,066
Resource Group for Education and Advocacy for Community Health India Linkage to care to reduce pre-treatment loss to follow-up $584,286
Population Services Kenya Kenya Improving treatment adherence and outcomes $600,000
RedAid Nigeria Nigeria Linkage to care to reduce pre-treatment loss to follow-up $213,459
Janna Health Foundation Nigeria Improving treatment adherence and outcomes $582,398
DOPASI Foundation Pakistan Improving treatment adherence and outcomes $598,819
CTY TNHH (IRD VN) Viet Nam Implementation of new DR-TB treatment regimens $600,000
The Union Zimbabwe Trust Zimbabwe Implementation of new DR-TB treatment regimens $599,995